The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Annamayya district administration implements strategic plan to combat drug abuse, urging public to report any related ...

In talks at the annual meeting of the American Society of Clinical Oncology (ASCO), experts from Roswell Park Comprehensive Cancer Center will give remarks on racial and ethnic disparities in outcomes ...